Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Mustazzolu

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Tuberculosis (Edinburgh, Scotland)|June 8, 2024
Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overviewAndrea Sanchini, Alessio Lanni, Federico Giannoni, et al.
Mediterranean Journal of Hematology and Infectious Diseases|December 24, 2013
Targeting dormant bacilli to fight tuberculosisLanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, et al.
International Journal of Mycobacteriology|August 5, 2017
Fighting tuberculosis by drugs targeting nonreplicating <i>Mycobacterium tuberculosis</i> bacilliAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Journal of Clinical Microbiology|September 15, 2017
Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide ResistanceAlessandro Mustazzolu, Angelo Iacobino, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosisGiovanni Piccaro, Donatella Pietraforte, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2016
Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pHAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditionsGiovanni Piccaro, Federico Giannoni, Perla Filippini, et al.
Annali Dell'Istituto Superiore Di Sanita|April 11, 2019
Revisiting problems and solutions to decrease Mycobacterium tuberculosis pyrazinamide false resistance when using the Bactec MGIT 960 systemAlessandro Mustazzolu, Claudio Piersimoni, Angelo Iacobino, et al.
Journal of Clinical Microbiology|October 27, 2012
Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculumClaudio Piersimoni, Alessandro Mustazzolu, Federico Giannoni, et al.
The European Respiratory Journal|May 5, 2018
Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016Alessandro Mustazzolu, Emanuele Borroni, Daniela Maria Cirillo, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Tuberculosis (Edinburgh, Scotland)|June 8, 2024
Exploring diagnostic methods for drug-resistant tuberculosis: A comprehensive overviewAndrea Sanchini, Alessio Lanni, Federico Giannoni, et al.
Mediterranean Journal of Hematology and Infectious Diseases|December 24, 2013
Targeting dormant bacilli to fight tuberculosisLanfranco Fattorini, Giovanni Piccaro, Alessandro Mustazzolu, et al.
International Journal of Mycobacteriology|August 5, 2017
Fighting tuberculosis by drugs targeting nonreplicating <i>Mycobacterium tuberculosis</i> bacilliAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Journal of Clinical Microbiology|September 15, 2017
Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide ResistanceAlessandro Mustazzolu, Angelo Iacobino, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy|October 8, 2014
Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosisGiovanni Piccaro, Donatella Pietraforte, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy|December 21, 2016
Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pHAngelo Iacobino, Giovanni Piccaro, Federico Giannoni, et al.
Antimicrobial Agents and Chemotherapy|January 9, 2013
Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditionsGiovanni Piccaro, Federico Giannoni, Perla Filippini, et al.
Annali Dell'Istituto Superiore Di Sanita|April 11, 2019
Revisiting problems and solutions to decrease Mycobacterium tuberculosis pyrazinamide false resistance when using the Bactec MGIT 960 systemAlessandro Mustazzolu, Claudio Piersimoni, Angelo Iacobino, et al.
Journal of Clinical Microbiology|October 27, 2012
Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculumClaudio Piersimoni, Alessandro Mustazzolu, Federico Giannoni, et al.
The European Respiratory Journal|May 5, 2018
Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016Alessandro Mustazzolu, Emanuele Borroni, Daniela Maria Cirillo, et al.
Pageof 2